ID: ALA4782479

Max Phase: Preclinical

Molecular Formula: C18H15NO6

Molecular Weight: 341.32

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  COc1cc(/C=C/c2cccc3c2oc(=O)n3CC(=O)O)ccc1O

Standard InChI:  InChI=1S/C18H15NO6/c1-24-15-9-11(6-8-14(15)20)5-7-12-3-2-4-13-17(12)25-18(23)19(13)10-16(21)22/h2-9,20H,10H2,1H3,(H,21,22)/b7-5+

Standard InChI Key:  JBGXUAJVCINONB-FNORWQNLSA-N

Associated Targets(Human)

HEK-293T 167025 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Aldose reductase 4007 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Brain 4256 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Mus musculus 284745 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 341.32Molecular Weight (Monoisotopic): 341.0899AlogP: 2.56#Rotatable Bonds: 5
Polar Surface Area: 101.90Molecular Species: ACIDHBA: 6HBD: 2
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 3.36CX Basic pKa: CX LogP: 2.55CX LogD: -0.86
Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.69Np Likeness Score: -0.07

References

1. Zhang X,Chen H,Lei Y,Zhang X,Xu L,Liu W,Fan Z,Ma Z,Yin Z,Li L,Zhu C,Ma B.  (2021)  Multifunctional agents based on benzoxazolone as promising therapeutic drugs for diabetic nephropathy.,  215  [PMID:33588177] [10.1016/j.ejmech.2021.113269]

Source